These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25939819)

  • 1. Consequences of additional use of contrast-enhanced (18)F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer.
    Li XX; Liu NB; Zhu L; Yuan XK; Yang CW; Ren P; Gong LL; Zhao LJ; Xu WG; Wang P
    Br J Radiol; 2015 Jul; 88(1051):20140590. PubMed ID: 25939819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma.
    Vees H; Casanova N; Zilli T; Imperiano H; Ratib O; Popowski Y; Wang H; Zaidi H; Miralbell R
    Radiat Oncol; 2012 Oct; 7():176. PubMed ID: 23088346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric comparison and biological evaluation of PET- and CT-based target delineation for LA-NSCLC using auto-planning.
    Shao Y; Wang H; Chen H; Gu H; Duan Y; Feng A; Li X; Xu Z
    Phys Med; 2019 Nov; 67():77-84. PubMed ID: 31678800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
    Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
    Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer.
    Thureau S; Dubray B; Modzelewski R; Bohn P; Hapdey S; Vincent S; Anger E; Gensanne D; Pirault N; Pierrick G; Vera P
    Radiat Oncol; 2018 Oct; 13(1):208. PubMed ID: 30352608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?
    Walter F; Jell C; Zollner B; Andrae C; Gerum S; Ilhan H; Belka C; Niyazi M; Roeder F
    Strahlenther Onkol; 2021 Sep; 197(9):780-790. PubMed ID: 33104815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine: final results of the VortigERN study.
    Chatterjee S; Frew J; Mott J; McCallum H; Stevenson P; Maxwell R; Wilsdon J; Kelly CG
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e173-9. PubMed ID: 23079100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of PET-CT in target volume delineation for three-dimensional conformal radiotherapy in patients with non-small cell lung cancer and atelectasis.
    Yin LJ; Yu XB; Ren YG; Gu GH; Ding TG; Lu Z
    Multidiscip Respir Med; 2013 Mar; 8(1):21. PubMed ID: 23506629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geometrical differences in target volumes based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography and four-dimensional computed tomography maximum intensity projection images of primary thoracic esophageal cancer.
    Guo Y; Li J; Wang W; Zhang Y; Wang J; Duan Y; Shang D; Fu Z
    Dis Esophagus; 2014; 27(8):744-50. PubMed ID: 24915760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
    Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
    Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
    Dalah E; Moraru I; Paulson E; Erickson B; Li XA
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18-Fluorodeoxy-Glucose Positron Emission Tomography- Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy.
    Dębiec K; Wydmański J; Gorczewska I; Leszczyńska P; Gorczewski K; Leszczyński W; d’Amico A; Kalemba M
    Asian Pac J Cancer Prev; 2017 Nov; 18(11):2989-2998. PubMed ID: 29172270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinoma.
    Topkan E; Yavuz AA; Aydin M; Onal C; Yapar F; Yavuz MN
    J Exp Clin Cancer Res; 2008 Sep; 27(1):41. PubMed ID: 18808725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
    Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
    Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (
    Berwouts D; De Wolf K; De Neve W; Olteanu LA; Lambert B; Speleers B; Goethals I; Madani I; Ost P
    J Med Imaging Radiat Oncol; 2017 Feb; 61(1):124-132. PubMed ID: 27527354
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhao L; Chen S; Chen S; Pang Y; Dai Y; Hu S; Lin L; Fu L; Sun L; Wu H; Chen H; Lin Q
    Radiother Oncol; 2021 May; 158():55-61. PubMed ID: 33621587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of computed tomography and [18F] fluorodeoxyglucose positron emission tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiation.
    Ceresoli GL; Cattaneo GM; Castellone P; Rizzos G; Landoni C; Gregorc V; Calandrino R; Villa E; Messa C; Santoro A; Fazio F
    Tumori; 2007; 93(1):88-96. PubMed ID: 17455878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of computed tomography- and positron emission tomography-based radiotherapy planning in cholangiocarcinoma.
    Onal C; Topuk S; Yapar AF; Yavuz M; Topkan E; Yavuz A
    Onkologie; 2013; 36(9):484-90. PubMed ID: 24051924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of primary tumour volumes delineated on four-dimensional computed tomography maximum intensity projection and (18) F-fluorodeoxyglucose positron emission tomography computed tomography images of non-small cell lung cancer.
    Duan Y; Li J; Zhang Y; Wang W; Sun X; Fan T; Shao Q; Xu M; Guo Y; Shang D
    J Med Imaging Radiat Oncol; 2015 Oct; 59(5):623-30. PubMed ID: 25754243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.